Frank R. Witney Witney

Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001.

Since its founding in 1986, Applied Precision has grown into a leader in the development, manufacture and supply of high-performance image acquisition and analysis systems for the life science industries. The company's products play a key role in providing the quantifiable data and meaningful information needed to advance technology and realize important scientific discoveries. The company's culture encourages teamwork, recognizes the importance of balancing work with personal time and rewards innovative thinking. Today, Applied Precision has a commanding technology lead in its served markets, and has earned awards for its innovative products and strong financial growth, including winning the Deloitte & Touche Washington State Technology Fast 50 award on four separate occasions. The company employs approximately 180 engineers, technicians, managers and sales and marketing professionals at its Seattle-based headquarters, as well as in its sales and service centers throughout Europe and Asia. Applied Precision's Corporate Headquarters are located in the Pacific Northwest, 15 miles east of Seattle, in Issaquah, Washington. Its call centers are located in Marlborough, one hour west of London, England and in Hsin-Chu City, Taiwan.

PerkinElmer Life Sciences, Inc. Provided drug discovery, life science research and clinical screening services. It was headquartered in Boston, MA.

On July 13, 2001, the company entered into a merger agreement with PerkinElmer, Inc. Pursuant to the merger agreement, the company will become a subsidiary of PerkinElmer and each outstanding share of the company's common stock will be converted into 0.311 of a share of PerkinElmer common stock

One Lambda, Inc. provides transplantation services. The firm offers antibody detection, serology, molecular typing instruments and software products. The company was founded by Paul I. Terasaki in 1984 and is headquartered in Canoga Park, CA.

Dionex Corp. develops, manufactures, sells, and services chromatography and extraction systems for separating, isolating, and identifying the components of chemical mixtures. The firm's products are used extensively by the environmental, life science, pharmaceutical, food and beverage, chemicals, electronics and power industries. The company was founded in 1975 and is headquartered in Sunnyvale, CA.

Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA.

DVS Sciences Inc. develops analytical equipment and reagent for CyTOF instrument. The company was founded by Dmitry Bandura, Vladimir Baranov, Scott Tanner and olga Ornatsky in 2004 and is headquartered in Sunnyvale, CA.

RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

eBioscience, Inc. manufactures staple research reagents. The company was founded in 1999 and is headquarter in Santa Clara, CA.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

GenapSys, Inc. develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing. It also develops gene electronic nano-integrated ultra-sensitive platform device for chip-based DNA sequencing. The company was founded by Hesaam Esfandyarpour in 2010 and is headquartered in Redwood, CA.

Nexcelom Bioscience LLC operates as a cell counting solution company. It manufactures, designs, and develops devices and instruments for cell-cased assay used in cancer research and drug discovery. The firm offers Cellometer mini cell viability, Cellometer auto 1000 cell viability counter, Cellometer auto 2000 cell viability counter, cell-based assay kits, and Nexcelom ULA round bottom multi-well plates products. The company was founded by Jean Qiu in 2003 and is headquartered in Lawrence, MA.

Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO.

Jumpcode Genomics, Inc. provides healthcare services. The company is headquartered in Carlsbad, CA.

PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium.

Leinco Technologies, Inc. is a specialty manufacturer of early discovery research products, including antibodies, recombinant proteins, ELISA kits, and other life sciences products. Leinco Technologies is based in St. Louis, MO, and operates out of a 27,000 square foot facility with significant laboratory space to service all customer and regulatory requirements. The company also offers a full suite of custom development and manufacturing services and serves leading drug discovery and in vitro diagnostic companies around the world. The company was founded in 1992 by Patrick Leinert, who has been the CEO since then.